000			02243 a2200577 4500
005			20250516003603.0
264		0	_c20110103
008			201101s 0 0 eng d
022			_a1365-2141
024	7		_a10.1111/j.1365-2141.2010.08340.x _2doi
040			_aNLM _beng _cNLM
100	1		_aAgathocleous, Agathoclis
245	0	0	_aWeekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemia. _h[electronic resource]
260			_bBritish journal of haematology _cNov 2010
300			_a346-53 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aBoronic Acids _xadministration & dosage
650	0	4	_aBortezomib
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHematologic Diseases _xchemically induced
650	0	4	_aHumans
650	0	4	_aLymphoma, Follicular _xdrug therapy
650	0	4	_aLymphoma, Mantle-Cell _xdrug therapy
650	0	4	_aLymphoproliferative Disorders _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPyrazines _xadministration & dosage
650	0	4	_aRituximab
650	0	4	_aSurvival Analysis
650	0	4	_aTreatment Outcome
650	0	4	_aWaldenstrom Macroglobulinemia _xdrug therapy
700	1		_aRohatiner, Ama
700	1		_aRule, Simon
700	1		_aHunter, Hannah
700	1		_aKerr, Jonathan Paul
700	1		_aNeeson, Susan M
700	1		_aMatthews, Janet
700	1		_aStrauss, Sandra
700	1		_aMontoto, Silvia
700	1		_aJohnson, Peter
700	1		_aRadford, John
700	1		_aLister, Andrew
773	0		_tBritish journal of haematology _gvol. 151 _gno. 4 _gp. 346-53
856	4	0	_uhttps://doi.org/10.1111/j.1365-2141.2010.08340.x _zAvailable from publisher's website
999			_c20208557 _d20208557